AwardedDNKGoodsFramework agreement
Hepatitis vacciner 2026-2030
- Published
- Published 27 February 2026
- Deadline
- Closed 31 March 2026
Overview
Statens Serum Institut procured hepatitis vaccines through three separate framework agreements for Hepatitis A, Hepatitis B, and Hepatitis A+B vaccines for children and adults, covering the period 2026–2030. The contract was awarded to GlaxoSmithKline Pharma A/S on 26 May 2026 for a value of 3 DKK.
Key details
- Country
- DNK
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 27 February 2026
- Deadline
- Closed
VaccinesHepatitis B vaccines
Award outcome
- Awarded value
- DKK 3
- Award date
- 26 May 2026
- Contract period
- — → 5 May 2030
- GlaxoSmithKline Pharma A/S
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
25 June 2026
Contract Notice
27 February 2026
Contracting authority
Statens Serum Institut
Procuring entityKøbenhavn S, DNK
002: 46 83 74 28
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.